Singulus Technologies (SNG) Q2 2024 earnings summary

Executive summary

• Order intake doubled year-over-year to €52.3 million, with order backlog rising to €70.4 million.

• Sales for H1 2024 were €40.7 million, nearly flat compared to €41.7 million in H1 2023.

• EBIT turned positive at €1.2 million for H1 2024, up from €-0.7 million in H1 2023.

• Gross margin improved to 31.8% from 26.7% year-over-year.

• Financing reorganization completed; liquidity secured through shareholder support.

Financial highlights

• H1 2024 revenue: €40.7 million (H1 2023: €41.7 million).

• EBIT: €1.2 million (H1 2023: €-0.7 million); EBITDA: €2.5 million (H1 2023: €0.7 million).

• Net loss for H1 2024: €-0.2 million (H1 2023: €-1.8 million).

• Operating cash flow: €-7.6 million (H1 2023: €-20.6 million).

• Shareholders' equity: €-44.8 million (Dec 2023: €-44.6 million).

Outlook and guidance

• 2024 sales forecast reduced to €95–105 million (previously €120–130 million).

• EBIT guidance for 2024 set at €3.0–6.5 million.

• Optimism for continued growth in Semiconductor and Life Science segments.

• Achievement of forecast depends on timely project completions and new orders.